Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo - Fakhrudin, N; Waltenberger, B; Cabaravdic, M; Atanasov, A G; Malainer, C; Schachner, D; Heiss, E H; Liu, R; Noha, S M; Grzywacz, A M; Mihaly-Bison, J; Awad, E M; Schuster, D; Breuss, J M; Rollinger, J M; Bochkov, V; Stuppner, H; Dirsch, V M (Br J Pharmacol, 2014)